I

Innova Captab Ltd
NSE:INNOVACAP

Watchlist Manager
Innova Captab Ltd
NSE:INNOVACAP
Watchlist
Price: 975.4 INR -1.15% Market Closed
Market Cap: 55.8B INR
Have any thoughts about
Innova Captab Ltd?
Write Note

Innova Captab Ltd
Cash & Cash Equivalents

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Innova Captab Ltd
Cash & Cash Equivalents Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Cash & Cash Equivalents CAGR 3Y CAGR 5Y CAGR 10Y
I
Innova Captab Ltd
NSE:INNOVACAP
Cash & Cash Equivalents
â‚ą117.3m
CAGR 3-Years
35%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Divi's Laboratories Ltd
NSE:DIVISLAB
Cash & Cash Equivalents
â‚ą3.4B
CAGR 3-Years
-46%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Suven Life Sciences Ltd
NSE:SUVEN
Cash & Cash Equivalents
â‚ą924.9m
CAGR 3-Years
100%
CAGR 5-Years
9%
CAGR 10-Years
N/A
Dishman Carbogen Amcis Ltd
NSE:DCAL
Cash & Cash Equivalents
â‚ą3.9B
CAGR 3-Years
18%
CAGR 5-Years
27%
CAGR 10-Years
N/A
Syngene International Ltd
NSE:SYNGENE
Cash & Cash Equivalents
â‚ą2.2B
CAGR 3-Years
-13%
CAGR 5-Years
-1%
CAGR 10-Years
N/A
Vimta Labs Ltd
NSE:VIMTALABS
Cash & Cash Equivalents
â‚ą257.9m
CAGR 3-Years
56%
CAGR 5-Years
50%
CAGR 10-Years
21%
No Stocks Found

Innova Captab Ltd
Glance View

Market Cap
55.8B INR
Industry
Life Sciences Tools & Services

Innova Captab Ltd is a IN-based company operating in Life Sciences Tools & Services industry. The company is headquartered in Panchkula, Haryana. The company went IPO on 2023-12-29. Innova Captab Ltd is an integrated pharmaceutical company. The firm is engaged in the business of manufacturing and trading of drugs and pharmaceuticals. The company has presence across the pharmaceuticals value chain, including research and development, manufacturing, drug distribution and marketing and exports. Its business includes CDMO business, domestic branded generics business, and international branded generic product business. Its CDMO business provides research, product development and manufacturing services. Its branded generics business consists of the development, manufacture and distribution of generic formulation products, which are marketed and distributed in India under its own brand names through online and offline channels. Its generic drug products are also available online through various e-commerce pharmacy sites. The company has developed a diversified branded generics product portfolio including Tablets, capsules, dry syrups, dry powder injection, ointments and liquid orals.

INNOVACAP Intrinsic Value
813.53 INR
Overvaluation 17%
Intrinsic Value
Price
I

See Also

What is Innova Captab Ltd's Cash & Cash Equivalents?
Cash & Cash Equivalents
117.3m INR

Based on the financial report for Mar 31, 2024, Innova Captab Ltd's Cash & Cash Equivalents amounts to 117.3m INR.

What is Innova Captab Ltd's Cash & Cash Equivalents growth rate?
Cash & Cash Equivalents CAGR 3Y
35%

Over the last year, the Cash & Cash Equivalents growth was 233%. The average annual Cash & Cash Equivalents growth rates for Innova Captab Ltd have been 35% over the past three years .

Back to Top